Winfield Associates, Inc. - JPMORGAN CHASE & CO ownership

JPMORGAN CHASE & CO's ticker is AMJ and the CUSIP is 46625H365. A total of 305 filers reported holding JPMORGAN CHASE & CO in Q3 2014. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.

Quarter-by-quarter ownership
Winfield Associates, Inc. ownership history of JPMORGAN CHASE & CO
ValueSharesWeighting
Q2 2019$239,000
-16.4%
9,500
-15.2%
0.12%
-19.0%
Q1 2019$286,000
+12.6%
11,200
-1.8%
0.15%
-1.3%
Q4 2018$254,000
-23.5%
11,400
-5.8%
0.16%
-5.5%
Q3 2018$332,000
-9.0%
12,100
-12.0%
0.16%
-16.3%
Q2 2018$365,000
+10.6%
13,7500.0%0.20%
+10.1%
Q1 2018$330,000
+20.4%
13,750
+38.2%
0.18%
+28.1%
Q4 2017$274,000
-7.4%
9,950
-5.2%
0.14%
-10.9%
Q3 2017$296,000
+5.0%
10,500
+10.5%
0.16%0.0%
Q2 2017$282,000
-9.9%
9,500
-2.1%
0.16%
-12.4%
Q1 2017$313,000
+2.0%
9,7000.0%0.18%
-5.3%
Q4 2016$307,000
+2.7%
9,700
+2.1%
0.19%0.0%
Q3 2016$299,000
+14.6%
9,500
+15.9%
0.19%
+10.6%
Q2 2016$261,000
+108.8%
8,200
+78.3%
0.17%
+100.0%
Q1 2016$125,000
-6.0%
4,6000.0%0.08%
-4.5%
Q4 2015$133,000
-68.4%
4,600
-66.8%
0.09%
-71.7%
Q3 2015$421,000
-73.8%
13,850
-65.9%
0.32%
-71.4%
Q2 2015$1,609,000
-5.9%
40,625
+1.8%
1.10%
-8.1%
Q1 2015$1,709,000
-7.0%
39,925
-0.1%
1.20%
-11.3%
Q4 2014$1,837,000
-22.1%
39,975
-10.0%
1.35%
-23.0%
Q3 2014$2,358,000
+6.9%
44,425
+5.5%
1.76%
+9.8%
Q2 2014$2,206,000
+25.3%
42,125
+11.4%
1.60%
+10.0%
Q1 2014$1,760,000
+1.1%
37,825
+0.7%
1.45%
+1.7%
Q4 2013$1,740,00037,5501.43%
Other shareholders
JPMORGAN CHASE & CO shareholders Q3 2014
NameSharesValueWeighting ↓
Arlington Partners LLC 813,278$19,519,00018.39%
BRIGHTON JONES LLC 3,046,021$73,105,00010.08%
FIDUCIARY COUNSELLING INC 86,004$2,064,0007.59%
CIBC BANK USA 2,219,539$53,269,0007.28%
Candlewood Investment Group, LP 42,000$1,008,0006.89%
BRR OpCo, LLC 976,226$23,429,0006.54%
DOW CHEMICAL CO /DE/ 678,000$16,272,0005.95%
Klingman & Associates, LLC 1,019,745$24,474,0005.49%
FFT WEALTH MANAGEMENT LLC 541,801$13,003,0005.09%
Gainplan LLC 125,000$3,000,0003.82%
View complete list of JPMORGAN CHASE & CO shareholders